XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.4
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Non-controlling Interests [Member]
Treasury Stock [Member]
Redeemable Equity [Member]
Preferred Stock [Member]
Stockholders equity, beginning of period at Feb. 28, 2022 $ 346,102 $ 267 $ 300,453 $ 126,573 $ (17,503) $ (35,000) $ (25,138) $ (3,550)
Net income (loss) (7,234)     (6,527)   (707)    
Other comprehensive income (loss), net of tax (1,375)       (1,375)      
Cash settlement of market stock units upon vesting of 80% of award (4,000)   (4,000)          
Net settlement of shares of Class A common stock upon vesting of stock awards, net of withholding taxes (403) 1 (404)          
Reclassification of stockholders' equity to redeemable equity (33)             (33)
Stock-based compensation expense 259   126         133
Stockholders equity, end of period at May. 31, 2022 333,316 268 296,175 120,046 (18,878) (35,707) (25,138) (3,450)
Stockholders equity, beginning of period at Feb. 28, 2022 346,102 267 300,453 126,573 (17,503) (35,000) (25,138) (3,550)
Other comprehensive income (loss), net of tax (2,348)              
Reclassification of stockholders' equity to redeemable equity (531)              
Stockholders equity, end of period at Nov. 30, 2022 325,443 268 296,456 117,251 (19,851) (36,772) (27,913) (3,996)
Stockholders equity, beginning of period at May. 31, 2022 333,316 268 296,175 120,046 (18,878) (35,707) (25,138) (3,450)
Net income (loss) (10,799)     (10,216)   (583)    
Other comprehensive income (loss), net of tax (1,989)       (1,989)      
Stock-based compensation expense (197)   136         (333)
Stockholders equity, end of period at Aug. 31, 2022 320,331 268 296,311 109,830 (20,867) (36,290) (25,138) (3,783)
Net income (loss) 6,939     7,421   (482)    
Other comprehensive income (loss), net of tax 1,016       1,016      
Repurchase of shares of Common Stock (2,775)           (2,775)  
Stock-based compensation expense (68)   145         (213)
Stockholders equity, end of period at Nov. 30, 2022 325,443 268 296,456 117,251 (19,851) (36,772) (27,913) (3,996)
Stockholders equity, beginning of period at Feb. 28, 2023 304,591 268 296,577 97,997 (18,680) (37,268) (30,285) (4,018)
Net income (loss) (11,387)     (10,738)   (649)    
Other comprehensive income (loss), net of tax 177       177      
Repurchase of shares of Common Stock (4,113)           (4,113)  
Stock-based compensation expense 235   258         (23)
Stockholders equity, end of period at May. 31, 2023 289,503 268 296,835 87,259 (18,503) (37,917) (34,398) (4,041)
Stockholders equity, beginning of period at Feb. 28, 2023 304,591 268 296,577 97,997 (18,680) (37,268) (30,285) (4,018)
Other comprehensive income (loss), net of tax 1,275       1,275      
Repurchase of shares of Common Stock (8,655)              
Reclassification of stockholders' equity to redeemable equity 0              
Stockholders equity, end of period at Nov. 30, 2023 277,327 268 297,220 79,232 (17,405) (38,961) (38,940) (4,087)
Stockholders equity, beginning of period at May. 31, 2023 289,503 268 296,835 87,259 (18,503) (37,917) (34,398) (4,041)
Net income (loss) (11,617)     (11,064)   (553)    
Prior period adjustment (Note 2) 1,125     1,125        
Other comprehensive income (loss), net of tax 849       849      
Repurchase of shares of Common Stock (2,859)           (2,859)  
Stock-based compensation expense 185   208         (23)
Stockholders equity, end of period at Aug. 31, 2023 277,186 268 297,043 77,320 (17,654) (38,470) (37,257) (4,064)
Net income (loss) 1,421     1,912   (491)    
Other comprehensive income (loss), net of tax 249       249      
Repurchase of shares of Common Stock (1,683)           1,683  
Stock-based compensation expense 154   177         (23)
Stockholders equity, end of period at Nov. 30, 2023 $ 277,327 $ 268 $ 297,220 $ 79,232 $ (17,405) $ (38,961) $ (38,940) $ (4,087)